ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,548Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 2680

$735K Total Retail Price of All Prescriptions

Rank: 142 out of 2680

481 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 8,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 470 392 1 1
OMEPRAZOLE 408 359 2 2
HYDROCHLOROTHIAZIDE 349 324 3 9
LEVOTHYROXINE SODIUM 326 242 4 4
LISINOPRIL 320 294 5 5
METOPROLOL TARTRATE 233 229 6 8
FUROSEMIDE 216 175 7 7
PRAVASTATIN SODIUM 214 164 8 16
AMLODIPINE BESYLATE 176 156 9 3
RAMIPRIL 174 153 10 49
ATORVASTATIN CALCIUM 163 138 11 10
DONEPEZIL HCL 160 136 12 28
WARFARIN SODIUM 158 130 13 12
METOPROLOL SUCCINATE 145 127 14 11
SPIRIVA 140 139 15 36
HYDROCODONE-ACETAMINOPHEN 140 96 S3 15 13
POTASSIUM CHLORIDE 137 110 17 29
NEXIUM 128 109 18 19
METFORMIN HCL ER 128 110 18 53
CRESTOR 125 101 20 15
ATENOLOL 122 121 21 14
ALENDRONATE SODIUM 116 60 22 20
TAMSULOSIN HCL 113 94 23 25
JANUVIA 109 109 24 34
SERTRALINE HCL 103 77 25 23
METFORMIN HCL 86 71 26 6
FLUOXETINE HCL 85 54 27 76
TRAMADOL HCL 82 63 28 33
LOVASTATIN 82 80 28 37
TORSEMIDE 73 70 30 169
CARVEDILOL 72 47 31 27
ALLOPURINOL 69 68 32 42
DIOVAN 69 64 32 26
CELEBREX 68 61 34 75
BENZTROPINE MESYLATE 65 54 R 35 193
CITALOPRAM HBR 65 43 35 22
LANSOPRAZOLE 64 51 37 121
PROAIR HFA 64 45 37 52
ZETIA 63 50 39 69
LOSARTAN POTASSIUM 61 60 40 18
ENALAPRIL MALEATE 59 45 41 24
RISPERIDONE 58 25 42 67
GLIMEPIRIDE 58 52 42 51
FENOFIBRATE 58 58 42 77
FINASTERIDE 57 57 45 80
FAMOTIDINE 56 40 46 65
CALCITONIN-SALMON 53 32 47 265
THIORIDAZINE HCL 53 30 R 47 358
GABAPENTIN 53 53 47 21
ZOLPIDEM TARTRATE 53 44 47 17
PAROXETINE HCL 52 43 51 62
NAMENDA 52 52 51 43
BISOPROLOL FUMARATE 52 49 51 163
CLOPIDOGREL 51 49 54 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.